Back to Companies
Inhibikase Therapeutics, Inc.
IKTNasdaqCIK: 0001750149
Recent Form 4 activity at Inhibikase Therapeutics, Inc. (IKT) spans 19 filings across 11 insiders (all of them on the buy side). Purchases total $3.0M against $0 in sales — heavily weighted toward buying, for a net purchase of $3.0M. Iwicki Mark T is the most active by dollar volume, and the single largest transaction was $10.0M by Iwicki Mark T. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$18.7M
Purchases
$3.0M
Sales
$0
Unique Insiders
11
Recent Insider Trades
19 loaded
| Jul 31 | IKT Inhibikase Therapeutics, Inc. | BERMAN DENNIS N | Insider | Exercise | $55.1K |
| Jul 31 | IKT Inhibikase Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $18.0K |
| Jul 17 | IKT Inhibikase Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Other | $0 |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | Bellini Roberto | Insider | Award | $296.1K |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | Aurentz Vincent | Insider | Award | $296.1K |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | BERMAN DENNIS N | Insider | Award | $296.1K |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | Kush Arvind | Insider | Award | $296.1K |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | Canner David | Insider | Award | $296.1K |
| Jun 30 | IKT Inhibikase Therapeutics, Inc. | Munshi Amit | Insider | Award | $296.1K |
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Disposed | $0 |
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Aurentz Vincent | Insider | Disposed | $0 |
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Munshi Amit | Insider | Disposed | $0 |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | Iwicki Mark T | Insider | Award | $10.0M |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Award | $1.8M |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | McIntyre David | Insider | Award | $2.0M |
| Nov 24 | IKT Inhibikase Therapeutics, Inc. | Sands Capital Life Sciences Pulse Fund II, L.P. | 10% Owner | Buy | $3.0M |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Aurentz Vincent | Insider | Other | $0 |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Other | $0 |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Munshi Amit | Insider | Grant | $0 |
19 filings